NYSE
417.56USD
+5.69 (+1.38%)
We have scored 64 news catalysts on Humana Inc. (HUM) over the past 12 months. The biggest single-day move next to one of them came Oct 9, 2026, when HUM closed +11.6%: “Humana Surges On 2027 CMS Ratings, Technical Breakout, Shares Fairly Priced”. Coverage across the window leans mixed (average ticker sentiment −0.03). Most of the impact sits in sector healthcare and price momentum.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
50.1B
P/E
—
EPS
—
Beta
0.74
52W range
163.11-456.5
Day range
408.79–418.56
Open
415.95
Prev close
411.87
Volume
1M
Avg volume
1.3M
Dividend
3.54
IPO
1981-12-31
Analysts publish price targets on HUM, and they disagree. Where the share price actually sits among them shows which of their arguments the market is buying — and which it is ignoring.
26 analyst price targets from $217 to $513
as of 2026-09-01
The market is within 5% of the median target — broadly agreeing with the analysts.
The reconstruction
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about Humana Inc. — not a sector bucket. Click an edge to see the articles that established the link.
Suppliers, customers, partners and competitors of Humana Inc., taken from what the news actually said about them rather than from a sector bucket. The count is how many articles established each link.
Latest scored catalyst for HUM: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Humana Inc., a prominent health and well-being enterprise, operates across the United States through its various subsidiary companies. Its operational structure is divided into three main segments: Retail, Group and Specialty, and Healthcare Services. The firm provides a wide array of medical and supplementary insurance plans directly to individual consumers. Furthermore, Humana collaborates with government entities; it holds a contract with the Centers for Medicare and Medicaid Services (CMS) to manage the Limited Income Newly Eligible Transition (LI NET) prescription drug program. The company also secures agreements with numerous states to deliver Medicaid, dual-eligible, and long-term care support benefits. For employer groups and individuals, Humana furnishes fully insured commercial medical and specialized health coverage, which encompasses dental, vision, and other ancillary health benefits. They additionally offer administrative services only (ASO) solutions and extend support to military personnel through contracts like the TRICARE T2017 East Region. Beyond insurance products, the company delivers comprehensive healthcare services directly. These include pharmacy management, provider network services, and a suite of home-based solutions such as home health care, serving both its own health plan enrollees and external clients. By the close of 2021 (December 31), Humana's reach extended to approximately 17 million individuals enrolled in its medical benefit plans and an additional 5 million utilizing its specialized product offerings. Established in 1961, Humana Inc. maintains its corporate headquarters in Louisville, Kentucky.
The price sits near the median of 26 published models, agreeing with the endorsed consensus that the company will recover, but it explicitly rejects the 34% upside of the bull case and the 35% downside of the bear case.
What the disagreement turns on
Whether Humana can actually deliver its targeted 3% pretax margin by 2028 despite lower Star Ratings and high pharmacy costs, a question that wired unit volume data can partially answer by tracking membership retention after the 600,000 planned plan exits.
The price pays for
It declines to pay for
Written by a language model from the published models, the reported segments and a reverse-DCF — not a recommendation, and not a house view.
Claim by claim
Computed at $383 on 2026-09-01 — the quote has since moved +9%, so read this as a record of what was priced in then, not now.
